|
Model Number PCO9X |
Device Problems
Adverse Event Without Identified Device or Use Problem (2993); Patient Device Interaction Problem (4001)
|
Patient Problems
Abdominal Pain (1685); Abscess (1690); Adhesion(s) (1695); Diarrhea (1811); Fistula (1862); Hematoma (1884); Low Blood Pressure/ Hypotension (1914); Unspecified Infection (1930); Inflammation (1932); Nausea (1970); Necrosis (1971); Pain (1994); Perforation (2001); Scar Tissue (2060); Seroma (2069); Vomiting (2144); Chills (2191); Hernia (2240); Discomfort (2330); Impaired Healing (2378); Obstruction/Occlusion (2422); Fluid Discharge (2686); Nodule (4551); Unspecified Tissue Injury (4559); Appropriate Clinical Signs, Symptoms, Conditions Term / Code Not Available (4581)
|
Event Type
Injury
|
Manufacturer Narrative
|
If information is provided in the future, a supplemental report will be issued.
|
|
Event Description
|
The patient¿s attorney alleged a deficiency against the device.The product was used for therapeutic treatment of an abdominal hernia.It was reported that after implant, the patient experienced chronic abdominal pain, abscess, adhesions, recurrence, chronic pain, and discomfort.Post-operative patient treatment included revision surgery and mesh removal.
|
|
Event Description
|
The patient¿s attorney alleged a deficiency against the device.The product was used for therapeutic treatment of an abdominal hernia.It was reported that after implant, the patient experienced chronic abdominal pain, abscess, adhesions, recurrence, chronic pain, infection, open draining wound, and discomfort.Post-operative patient treatment included revision surgery and mesh removal.
|
|
Manufacturer Narrative
|
Medtronic is submitting this report to comply with fda reporting regulations under 21 cfr parts 4 and 803.This report is based upon information obtained by medtronic, which the company may not have been able to fully investigate or verify prior to the date the report was required by the fda.Medtronic has made reasonable efforts to obtain more complete information and has provided as much relevant information as is available to the company as of the submission date of this report.This report does not constitute an admission or a conclusion by fda, medtronic, or its employees that the device, medtronic, or its employee caused or contributed to the event described in the report.In particular, this report does not constitute an admission by anyone that the product described in this report has any ¿defects¿ or has ¿malfunctioned¿.These words are included in the fda 3500a form and are fixed items for selection created by the fda to categorize the type of event solely for the purpose of regulatory reporting.Medtronic objects to the use of these words and others like them because of the lack of definition and the connotations implied by these terms.This statement should be included with any information or report disclosed to the public under the freedom of information act.Any required fields that are unpopulated are blank because the information is currently unknown or unavailable.A good faith effort will be made to obtain the applicable information relevant to the report.If information is provided in the future, a supplemental report will be issued.
|
|
Manufacturer Narrative
|
(patient codes, ime e2402: ileus, induration, pneumoperitoneum) medtronic submits this report to comply with fda regulations 21 cfr parts 4 and 803.Medtronic has made reasonable efforts to provide as much relevant information as is available to the company as of the submission date of this report.This report does not constitute an admission or a conclusion by fda, medtronic, or its employees that the device, medtronic, or its employee caused or contributed to the event described in the report.Medtronic will submit a supplemental report if additional relevant information becomes known.
|
|
Event Description
|
The patient¿s attorney alleged a deficiency against the device.The product was used for a laparoscopic therapeutic treatment of an ventral abdominal hernia.It was reported that after implant, the patient experienced chronic abdominal pain, abscess, adhesions, recurrence, chronic pain, infection, open draining wound, discomfort, fat necrosis, ileus, indurated mass, nausea, vomiting, diarrhea, chills, partial small bowel obstruction, hypotension, pneumoperitoneum, & scarring.Post-operative patient treatment included revision surgery, mesh removal, x-ray, hospitalization, excision of abscess, iv fluids, iv/oral pain medication, iv anti-nausea medication, diagnostic lap, lysis of adhesions, & tap block.
|
|
Manufacturer Narrative
|
Additional info: b2 (added disability), h6 (patient codes, device code).Medtronic submits this report to comply with fda regulations 21 cfr parts 4 and 803.Medtronic has made reasonable efforts to provide as much relevant information as is available to the company as of the submission date of this report.This report does not constitute an admission or a conclusion by fda, medtronic, or its employees that the device, medtronic, or its employee caused or contributed to the event described in the report.Medtronic will submit a supplemental report if additional relevant information becomes known.
|
|
Event Description
|
The patient¿s attorney alleged a deficiency against the device.The product was used for a laparoscopic therapeutic treatment of an ventral abdominal hernia.It was reported that after implant, the patient experienced hematoma, inflammation, fistula, seroma, perforation, mobility issues, chronic abdominal pain, abscess, adhesions, recurrence, chronic pain, infection, open draining wound, discomfort, fat necrosis, ileus, indurated mass, nausea, vomiting, diarrhea, chills, partial small bowel obstruction, hypotension, pneumoperitoneum, <(>&<)> scarring.Post-operative patient treatment included medication, cholecystectomy, revision surgery, mesh removal, x-ray, hospitalization, excision of abscess, iv fluids, iv/oral pain medication, iv anti-nausea medication, diagnostic lap, lysis of adhesions, <(>&<)> tap block.
|
|
Search Alerts/Recalls
|
|
|